Dr. Saxberg is the President of DDO Strategic Services, a consulting services company working with emerging companies seeking to take leading advantage of change driven by new technologies and information access in health care, with application to product research and development, product and service marketing, financial services innovation, and clinical service innovation.

Prior to founding DDO, Dr. Saxberg was Vice President, Corporate Staff, Advanced Communications for Johnson & Johnson. In that role, he led Johnson & Johnson’s efforts in medical informatics, focusing on new business opportunities related to information technology in healthcare delivery and product development. As part of these efforts, working with both internal and external venture capital resources as well as member companies, the Advanced Communications Group helped to develop for Johnson & Johnson pioneering creation or investment positions ranging from defined contribution employee benefit models of health insurance, real-time auto-adjudication networks at the point of care supporting cost-quality decisions between doctor and patient, and a variety of technologies in health informatics including telemedicine, clinical studies and outcomes measurement, and electronic medical records. Working with the Johnson & Johnson’s international pharmaceutical group, innovative programs were created in the development of iterative customer relationships based on clinical information, creating demonstration of product value. Dr. Saxberg and members of the Advanced Communications Group also led the development and implementation of Johnson & Johnson’s global policies and procedures for the Internet, including privacy policies, to construct a policy platform to enable future business needs.

Prior to joining Johnson & Johnson, Dr. Saxberg was a Senior Research Scientist with Eli Lilly, continuing his prior research interests in QSAR/genomics/proteomics/physiomics. In 1993, Dr. Saxberg was named Director of Information Sciences at Eli Lilly. In this role, he directed the group dedicated to corporate strategic planning and business development, with a particular focus on healthcare delivery systems and the consequent impact on the pharmaceutical industry. Before Eli Lilly, he spent two years as an N.I.H. Fellow at the Massachusetts Institute of Technology.

Dr. Saxberg is a member of the American Associate for the Advancement of Science, American Medical Association, American Medical Informatics Association, and IEEE. He is a management/advisory board member for a number of entrepreneurial companies and associations, including PhDx, Exagen, Medidata, the Institute for the Future, and the Columbia University Center for Advanced Technology.

Dr. Saxberg graduated summa cum laude from the University of Washington with an honors B.S. degree in Mathematics and an honors B.S. degree in Chemistry. He has completed an honors B.A./M.A. in Physics from Cambridge University in England. He received an M.D. degree from Harvard and his Ph.D. in Physics from the Massachusetts Institute of Technology.